Transmission-blocking antibodies against mosquito C-type lectins for dengue prevention

PLoS Pathog. 2014 Feb 13;10(2):e1003931. doi: 10.1371/journal.ppat.1003931. eCollection 2014 Feb.

Abstract

C-type lectins are a family of proteins with carbohydrate-binding activity. Several C-type lectins in mammals or arthropods are employed as receptors or attachment factors to facilitate flavivirus invasion. We previously identified a C-type lectin in Aedes aegypti, designated as mosquito galactose specific C-type lectin-1 (mosGCTL-1), facilitating the attachment of West Nile virus (WNV) on the cell membrane. Here, we first identified that 9 A. aegypti mosGCTL genes were key susceptibility factors facilitating DENV-2 infection, of which mosGCTL-3 exhibited the most significant effect. We found that mosGCTL-3 was induced in mosquito tissues with DENV-2 infection, and that the protein interacted with DENV-2 surface envelop (E) protein and virions in vitro and in vivo. In addition, the other identified mosGCTLs interacted with the DENV-2 E protein, indicating that DENV may employ multiple mosGCTLs as ligands to promote the infection of vectors. The vectorial susceptibility factors that facilitate pathogen invasion may potentially be explored as a target to disrupt the acquisition of microbes from the vertebrate host. Indeed, membrane blood feeding of antisera against mosGCTLs dramatically reduced mosquito infective ratio. Hence, the immunization against mosGCTLs is a feasible approach for preventing dengue infection. Our study provides a future avenue for developing a transmission-blocking vaccine that interrupts the life cycle of dengue virus and reduces disease burden.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Blocking / immunology
  • Antibodies, Blocking / pharmacology*
  • Culicidae
  • Dengue / immunology
  • Dengue / prevention & control*
  • Enzyme-Linked Immunosorbent Assay
  • Host-Parasite Interactions / immunology*
  • Immunoprecipitation
  • Insect Vectors / immunology
  • Lectins, C-Type / antagonists & inhibitors*
  • RNA Interference
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Antibodies, Blocking
  • Lectins, C-Type

Grants and funding

This work was funded by Grant for Grand Challenges Explorations of Bill & Melinda Gates Foundation (OPP1021992), National Key Basic Research Program of MOST (2013CB911500), National Science and Technology Mega Project for Infectious Diseases (2013ZX1004-610) and National Natural Science Foundation of China (81301412). GC is a Janssen Investigator of Tsinghua University and an Investigator of Center for Marine Medicine and Rescue of Tsinghua University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.